1. Market Research
  2. > Genomics Industry

Biomarker Industry, August 2017 Market Reports from Top Publishers

You might be interested in: Therapy, Laboratory, Diagnostics, Biopsy, Molecular Diagnostic, Cancer, Point Of Care Testing, Psychotic Disorder, Lung Cancer, Cancer Diagnostic, Cardiac Management, Genome Sequencing, Autoimmune Disease, Cancer Biomarker, Cardiac Monitoring, Vaccine, Arthritis, Bioinformatic, Dementia, Prostate Cancer.


 
1-10 of about 200 reports for Biomarker

Purchase Reports From Reputable Market Research Publishers

Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

  • $ 4000
  • Industry report
  • August 2017
  • by GlobalData

Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 Summary GlobalData’s Medical Devices sector report, “Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, ...

ASIA-PACIFIC CANCER BIOMARKER MARKET 2017-2025

  • $ 1238
  • Industry report
  • August 2017
  • by Inkwood Research

KEY FINDINGS The Asia-Pacific cancer biomarkers market is expected to speed up its growth with a CAGR of 15.73% for the years 2017-2025, generating a net worth of $8831 million. India is the fastest growing ...

EUROPE CANCER BIOMARKER MARKET FORECAST 2017-2025

  • $ 1238
  • Industry report
  • August 2017
  • by Inkwood Research

KEY FINDINGS The Europe cancer biomarker market is poised to grow at a CAGR of 13.46% for the years 2017-2025. The total income generated by the market is also predicted to increase to up to $8646 million ...

NORTH AMERICA CANCER BIOMARKER MARKET FORECAST 2017-2025

  • $ 1238
  • Industry report
  • August 2017
  • by Inkwood Research

KEY FINDINGS The United States is a primary contributor to the North American cancer biomarker market, which is all set to expand with a CAGR of 13.17% between the forecasted years of 2017-2025. The market ...

GLOBAL CANCER BIOMARKER MARKET FORECAST 2017-2025

  • $ 2475
  • Industry report
  • August 2017
  • by Inkwood Research

KEY FINDINGS The global cancer biomarker market is expected to grow at a CAGR of 14.07% between the years 2017- 2025, generating a net worth of $33026 million by the end of 2025. Some of the important ...

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

  • $ 4000
  • Industry report
  • August 2017
  • by GlobalData

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 Summary GlobalData’s Medical Devices sector report, “Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" ...

Global Cancer Biomarkers Market

  • $ 4250
  • Industry report
  • July 2017
  • by Mordor Intelligence LLP

The global biomarkers market was worth USD $ 25.3 billion in 2016 and it is expected to reach USD 39.2 billion by 2021 at a CAGR of 14.60%. Biomarkers are chemical, physical or biological parameters which ...

VolitionRX Ltd (VNRX) - Product Pipeline Analysis, 2017 Update

  • $ 750
  • Company report
  • July 2017
  • by GlobalData

Summary VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement ...

Banyan Biomarkers Inc - Product Pipeline Analysis, 2017 Update

  • $ 750
  • Company report
  • July 2017
  • by GlobalData

Summary Banyan Biomarkers Inc (Banyan Biomarkers) is a medical technology company that commercializes vitro diagnostic tests for the detection of traumatic brain injury and neurological diseases. The company’s ...

BioMarker Strategies LLC - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2017
  • by GlobalData

Summary BioMarker Strategies LLC (BioMarker Strategies) is a biotechnology company that develops tissue-based cancer diagnostic systems. The company offers cancer diagnostics system for predictive tests ...


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.